EIC Summit 2026: context and overview

The EIC Summit 2026 was held on 3 and 4 June at Tour & Taxis in Brussels. Organisers reported more than 2,000 attendees, 130 speakers and a dedicated exhibition where 23 EIC-backed projects presented technologies across health, energy, quantum, space and advanced manufacturing. The two-day programme combined policy panels, workshops for EIC awardees and multiple matchmaking formats aimed at accelerating the commercial uptake of deep-tech innovations developed in Europe.

The European Innovation Council made the EIC Business Acceleration Services, known as EIC BAS, the centrepiece of day one. The sessions mixed operational announcements, practical workshops and corporate matchmaking. The EIC also used the Summit to publish the EIC Impact Report 2026, which contains headline numbers on fundraising, co-investment and exits for EIC-backed companies.

What EIC Business Acceleration Services announced and why it matters

Speakers framed the EIC as more than a grant maker. The BAS messaging focused on hands-on support for market access, procurement, investor readiness and corporate partnerships. Agnieszka Stasiakowska, who heads the EIC BAS Global Offer, set out both achievements to date and operational changes for 2026 intended to turn EIC awards into commercial growth. Several quantitative claims were repeated on stage and in the Impact Report. They point to strong activity but require follow up to verify how many pilots become sustainable revenue streams.

Numbers presented at the Summit and in the EIC Impact Report 2026

Organisers presented two sets of figures at the Summit. One set referred to specific BAS programme outputs, and another came from the broader EIC Impact Report 2026. Both show scale but use different scopes and timeframes. Below is a compact presentation of those claims for comparison.

Numbers indicate significant activity and an increasingly mature financing ecosystem. Observers should note the distinction between services delivered by BAS and the broader investment outcomes reported by the EIC Fund and portfolio companies. The critical question is not initial engagement but measurable commercial scaling and durable jobs and revenues over a multi year horizon.

Workshops and practical sessions: themes and takeaways

Day one of the Summit hosted BAS workshops on internationalisation, fundraising, procurement, scaling strategy and inclusion. Sessions combined founder testimonies, investor panels and corporate participants. Several recurring themes stood out.

Working with international co investors and capital strategy

A session on working with US and other international co investors emphasised that attracting cross border capital is one step, while managing post deal integration and expectations is another. Practical items covered due diligence, term sheet dynamics and cultural differences in governance. A separate workshop focused on stage by stage capital strategy and recommended matching investor types to development phases. Panelists reiterated a core investor truth. Investors invest in teams as much as technology. They recommended diverse investor mixes to access complementary networks and capabilities and urged founders to anticipate next stage needs early.

Going global and international hubs

A session on internationalisation discussed regulatory complexity, cultural differences, funding mechanisms and emerging hubs such as Dubai. Presenters urged awardees to align internationalisation with the UN Sustainable Development Goals when relevant. The core message was pragmatic. Going global requires continuous market testing and adaptation rather than a one time market entry push.

Venture clienting and corporate adoption models

A keynote by Gregor Gimmy, founder of VentureClient.org, and a fireside chat with Victoria Hernández Valcárcel put venture clienting in the spotlight. Venture clienting describes a model where corporations act as early customers for startups rather than taking equity. The sessions argued this can be an effective path to scale when corporations provide fast deployment channels and domain expertise. The discussions stressed the need for C level buy in, dedicated governance and repeatable processes for enterprise level adoption.

Inclusion and leadership diversity

A practical workshop on building gender diverse leadership teams argued that diverse companies produce more innovation and better financial results. The session shared success cases and practical measures founders can take. Moderators emphasised that cultural change and targeted leadership development require ongoing support and metrics to show progress.

EIC Multi Corporate Day: life sciences matchmaking in practice

As part of the Corporate Partnership Programme the EIC ran a Multi Corporate Day on life sciences that matched 16 EIC-backed startups from nine countries with AstraZeneca, Bayer, Chiesi and Coloplast. Siemens Healthineers and Sanofi attended as observers. The activity combined two pitching rounds with structured one to one meetings, corporate briefings and preparatory coaching for the startups.

Corporates brought specific priorities to the event. AstraZeneca sought next generation therapeutics and sustainable chemistry. Bayer focused on drug discovery modalities and AI. Chiesi targeted respiratory and neonatal care with a cross cutting interest in health equity. Coloplast looked for non pharmacological solutions in stoma, bladder and bowel care. Participants reported that the pre selection and preparation accelerated technical conversations and made it feasible to scope pilots within a short timeframe.

The 16 selected EIC backed innovators who pitched included companies working on generative AI for synthetic clinical data, point of care liquid biopsy cartridges, exhaled biomarker platforms for respiratory care, gene writing platforms, lysosome targeting degrader therapies, microbiome analytics for stoma care, neonatal predictive AI and laser mediated intracellular delivery platforms among others. Organisers said tailored post event follow up will be provided over six months to help convert conversations into pilots and commercial agreements.

The activity illustrates the EIC approach of curating strategic corporate partners, preparing startups and then providing dealmaker support. This model increases the probability of initial pilots but does not guarantee scale. Corporate procurement, clinical validation and regulatory pathways in life sciences often take many months and require dedicated resources from both sides.

Exhibition presence and international partners

EIC BAS had a continuous presence on the exhibition floor with an open stand across both days. BAS coaches offered one to one guidance to awardees. Five international partner booths represented global ecosystems and soft landing partners from Canada, Japan, Singapore, South Korea and the United Arab Emirates. The partners included Toronto Business Development Centre, EU Japan Centre and JETRO, Singapore Economic Development Board, KITA and Dubai World Trade Centre. The intent was to give awardees direct access to local market experts and trade facilitation services.

What to watch and outstanding questions

The Summit presented a coherent narrative: fund deep tech, create hands on services and connect innovators to corporates, procurers and investors. The EIC Impact Report 2026 and BAS figures are useful indicators of momentum. Still, three questions remain central to assessing long term impact.

First, conversion from pilots to scaled commercial contracts. BAS reports numerous pilot matches, trade fair deals and procurement tenders won. The hard test is whether these interactions produce sustained revenue and follow on investment at scale.

Second, capacity and quality of new delivery mechanisms such as Key Account Managers and the corporate network. KAMs can reduce fragmentation only if they have sufficient sector knowledge and bandwidth. The corporate network will need to maintain quality of engagements rather than producing one off events.

Third, measurement and transparency. The Impact Report lists large aggregate numbers but tracking metrics such as time to revenue after a pilot, retention of talent and cross border job creation at company level will be important to verify claims about Europe becoming a deep tech scaling hub.

Recordings, access and next steps for innovators

Recordings of the Summit stages were made available for day one and day two sessions. EIC awardees can access BAS services via the EIC Community platform where open calls, partner offers and coaching opportunities are published. EIC BAS also promotes newsletters and open calls digests to surface opportunities for corporates, investors and procurers.

Final assessment

The EIC Summit 2026 demonstrated that the European Innovation Council is doubling down on services to turn research outputs into market facing companies. The ambition and operational detail are clearer than in earlier years. The practical interventions on corporate matchmaking, procurement and investor readiness reflect known gaps in European scale up ecosystems. The critical test will be longitudinal. Policymakers and ecosystem actors should expect progress but not instant transformation. Data transparency and careful tracking of pilot to market conversions will determine whether these services produce durable industrial deep tech champions across Europe.

Key people and organisations quoted or participating

Speakers and contributors included Agnieszka Stasiakowska head of EIC BAS Global Offer, Michiel Scheffer President of the Board of the EIC, Gregor Gimmy founder of VentureClient.org, Victoria Hernández Valcárcel Member of the EIC Board, Stéphane Ouaki Head of EIC Department at EISMEA and corporate representatives from AstraZeneca Bayer Chiesi and Coloplast. The Summit also featured 130 plus speakers across policy startups investors and corporates.

For more detailed lists of participating startups corporate partners and downloadable reports see the EIC Summit 2026 pages and the EIC Impact Report 2026.